LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...

A new, high-performance brain-computer interface (BCI) can be rapidly implanted through a minimally invasive procedure. The new BCI solution has been implanted in over 50 patients.

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

OpenAI has backed Merge Labs, a brain-computer interface startup co-founded by Sam Altman, as part of a $250 million seed ...

Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...

Merge Labs is a “research lab” dedicated to “bridging biological and artificial intelligence to maximize human ability.” ...

Signal Enhancement: An acoustic-driven signal enhancement approach based on NeRF acoustic field modeling and nested generative networks supplements missing or incomplete EEG data through acoustic ...

Merge Labs describes itself as "a research lab with the long-term mission of bridging biological and artificial intelligence ...

LumiMind, a next-generation neurotechnology company pioneering non-invasive, real-time neural modulation, will showcase ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

OpenAI-backed Merge Labs is working to safely interface biology, hardware devices, and AI at higher bandwidth.

The company will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...